Novo Nordisk (NVO)
39.20
-0.15 (0.38%)
Upcoming Events
Latest Headlines
Novo Nordisk (NVO) call put ratio 1.9 calls to 1 put amid price movement
October 21, 2026 5:10 AM - StreetInsider
Novo Nordisk CagriSema trial data show weight loss in women by menopause stage
October 20, 2026 9:17 AM - StreetInsider
Telsey analyzes GLP-1 drugs' impact on consumer sector
October 20, 2026 7:50 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Oct 19
October 19, 2026 8:31 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK280 at HSBC
October 19, 2026 1:31 AM - StreetInsider
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
October 16, 2026 8:35 AM - Globe NewsWire
Form 6-K NOVO NORDISK A S For: Oct 12
October 13, 2026 6:15 AM - SEC Filing
Novo Nordisk (NVO) PT Lowered to $40 at BMO Capital
October 12, 2026 9:53 AM - StreetInsider
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for October 13th – 15th
October 9, 2026 8:35 AM - Globe NewsWire
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK296 at Citi
October 9, 2026 6:19 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK225 at Deutsche Bank
October 7, 2026 4:26 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Oct 05
October 6, 2026 8:12 AM - SEC Filing
FDA extends review of Novo Nordisk's haemophilia A drug denecimig
October 5, 2026 6:04 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Oct 02
October 5, 2026 6:02 AM - SEC Filing
BTIG survey finds GLP-1 users cut 500 calories daily from diet
October 1, 2026 6:51 AM - StreetInsider
Novo Nordisk Wegovy data shows liver fat reduction in obesity trial
October 1, 2026 6:48 AM - StreetInsider
Novo Nordisk shares new CagriSema brain and metabolic study data
September 30, 2026 8:44 AM - StreetInsider
Novo Nordisk study shows weight loss in patients switching to oral Wegovy
September 30, 2026 6:03 AM - StreetInsider
BMO Capital Reiterates Market Perform Rating on Novo Nordisk (NVO)
September 29, 2026 9:35 AM - StreetInsider
Novo Nordisk licenses oral GLP-1/GIP dual agonist from Hengrui Pharma
September 29, 2026 6:05 AM - StreetInsider
Novo Nordisk study links semaglutide 2 mg to lower heart risk vs tirzepatide
September 29, 2026 6:04 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Sep 28
September 28, 2026 11:24 AM - SEC Filing
CMS pumps $51M into rural Texas to fight diabetes and obesity
September 28, 2026 10:10 AM - StreetInsider
Viatris sues Novo Nordisk over generic Wegovy patent dispute
September 25, 2026 3:25 PM - StreetInsider
Novo Nordisk open to direct New York listing, CEO Doustdar tells FT
September 23, 2026 12:14 AM - StreetInsider
CFRA Downgrades Novo Nordisk (NVO) to Sell
September 22, 2026 4:02 PM - StreetInsider
Roche obesity drug shows 15.5% weight loss in diabetes trial
September 22, 2026 7:26 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK245 at Deutsche Bank
September 22, 2026 2:37 AM - StreetInsider
Novo Resources Releases Updated Corporate Presentation
September 21, 2026 4:05 PM - StreetInsider
Form 6-K NOVO NORDISK A S For: Sep 21
September 21, 2026 11:12 AM - SEC Filing
Novo Nordisk shares drop as investor event disappoints
September 21, 2026 10:03 AM - StreetInsider
Novo Nordisk CagriSema shows weight loss edge over tirzepatide in trials
September 21, 2026 6:32 AM - StreetInsider
Novo Nordisk (NVO) call put ratio 1.8 calls to 1 put into hosting its Capital Markets Day
September 21, 2026 5:30 AM - StreetInsider
Novo Nordisk (NVO) Capital Markets Day preview
September 20, 2026 3:00 PM - StreetInsider
EMA panel backs Novo Nordisk's Sogroya for children's growth disorder
September 18, 2026 6:42 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Sep 17
September 17, 2026 12:21 PM - SEC Filing
EMA panel backs Novo Nordisk haemophilia A drug FREHEMGO
September 17, 2026 10:28 AM - StreetInsider
Novo Nordisk publishes phase 3b data on denecimig for haemophilia A
September 17, 2026 7:08 AM - StreetInsider
Novo Nordisk partners with Anthropic to turbocharge drug discovery
September 16, 2026 8:58 AM - StreetInsider
Novo Nordisk and Anthropic announce R&D collaboration
September 16, 2026 8:01 AM - StreetInsider
Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put into hosting Capital Markets Day
September 15, 2026 10:51 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Sep 14
September 15, 2026 6:17 AM - SEC Filing
Novo Nordisk (NVO) call put ratio 1.1 calls to 1 put into Capital Markets Day
September 15, 2026 6:03 AM - StreetInsider
Novo Nordisk rebrands to Novo with new cultural framework
September 14, 2026 6:00 AM - StreetInsider
Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight
September 11, 2026 2:20 AM - StreetInsider
Morgan Stanley Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Underweight
September 11, 2026 2:19 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK320 at HSBC
September 10, 2026 3:28 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Sep 07
September 9, 2026 6:04 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK300 at Barclays
September 8, 2026 5:39 AM - StreetInsider
BofA Securities Reiterates Neutral Rating on Novo Nordisk (NOVOB:DC) (NVO)
September 4, 2026 6:07 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 31
August 31, 2026 9:11 AM - SEC Filing
Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
August 27, 2026 8:59 AM - StreetInsider
Novo Nordisk seeks China approval for oral Wegovy drug
August 27, 2026 8:27 AM - StreetInsider
Deutsche Bank Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Sell
August 27, 2026 4:23 AM - StreetInsider
PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
August 25, 2026 1:54 PM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK275 at JPMorgan
August 25, 2026 4:28 AM - StreetInsider
Novo Resources Releases Updated Corporate Presentation
August 24, 2026 5:31 PM - Globe NewsWire
Form 6-K NOVO NORDISK A S For: Aug 24
August 24, 2026 10:50 AM - SEC Filing
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026 12:57 PM - Globe NewsWire
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"
August 18, 2026 11:05 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 17
August 18, 2026 6:05 AM - SEC Filing
Berenberg Downgrades Novo Nordisk (NVO) to Hold
August 12, 2026 3:06 AM - StreetInsider
Berenberg Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold
August 12, 2026 3:06 AM - StreetInsider
Novo Nordisk launches once-weekly basal insulin Awiqli nationwide
August 11, 2026 9:13 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 10
August 10, 2026 10:47 AM - SEC Filing
Form 6-K NOVO NORDISK A S For: Aug 06
August 10, 2026 10:42 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK310 at Citi
August 7, 2026 4:56 AM - StreetInsider
Novo Nordisk (NVO) PT Raised to $47 at BMO Capital
August 6, 2026 7:50 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK310 at Barclays
August 6, 2026 4:56 AM - StreetInsider
Novo Nordisk wins Dutch court order against Ceban over semaglutide
August 5, 2026 10:36 AM - StreetInsider
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
August 5, 2026 6:46 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jun 30
August 4, 2026 5:24 PM - SEC Filing
Form 6-K NOVO NORDISK A S For: Aug 04
August 4, 2026 1:40 PM - SEC Filing
Novo Nordisk raises 2026 outlook on stronger GLP-1 sales
August 4, 2026 12:34 PM - StreetInsider
Novo Nordisk (NVO) call put ratio 2.5 call to 1 put into quarter results
August 4, 2026 11:23 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 04
August 4, 2026 10:39 AM - SEC Filing
Novo Nordisk (NVO) call put ratio 1.9 calls to 1 put into quarter results
August 4, 2026 4:40 AM - StreetInsider
Novo Nordisk (NVO) call put ratio 1 call to 1 put into quarter results
August 3, 2026 11:00 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 31
July 31, 2026 8:55 AM - SEC Filing
Novo Nordisk stock tumbles 10% as key trial misses goal
July 31, 2026 8:11 AM - StreetInsider
Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
July 31, 2026 7:26 AM - StreetInsider
Novo Nordisk must face fraud lawsuit over CagriSema trial, judge rules
July 28, 2026 12:54 PM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 27
July 27, 2026 8:08 AM - SEC Filing
Lilly to file for next-gen obesity drug approval in early 2027
July 23, 2026 10:54 AM - StreetInsider
Full Article List
